SuperworthKura Oncology market cap KURA
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $854.9M
- Highest close in our data
- $2.4B
- Dec 2020
Kura Oncology is worth $854.9M at the close on Oct 23, 2026, at $9.61 a share.
That is up 2% over the last year and down 21% over five years.
Its highest close in our data was $2.4B in Dec 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $854.9M | $681.3M | $1.2B | −8% |
| 2025 | $925M | $466M | $1.1B | +37% |
| 2024 | $674.2M | $674.2M | $1.8B | −37% |
| 2023 | $1.1B | $568.7M | $1.1B | +29% |
| 2022 | $830.2M | $774.3M | $1.3B | −11% |
| 2021 | $931.8M | $813.3M | $2.2B | −50% |
| 2020 | $1.9B | $349.8M | $2.4B | +187% |
| 2019 | $644.8M | $544.3M | $878.5M | +26% |
| 2018 | $512M | $416.2M | $778.5M | +11% |
| 2017 | $462.3M | $129.3M | $500.1M | +267% |
| 2016 | $126.1M | $57.3M | $149.6M | −30% |
| 2015 | $179.5M | $117.1M | $232.1M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Kura Oncology's size, closest first, today.
| Company | Market cap |
|---|---|
| KURAKura Oncology | $854.9M |
| ABUSArbutus Biopharma | $831M |
| COLLCollegium Pharmaceutical | $747.5M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| CRMDCorMedix | $611.9M |
| OMEROmeros | $1.2B |
| ZVRAZevra Therapeutics | $582.6M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $568.9M |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| Peer median | $789.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Kura Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.